| GWAS identifies 14 loci for device-measured physical activity and sleep duration A Doherty, K Smith-Byrne, T Ferreira, MV Holmes, C Holmes, SL Pulit, ... Nature communications 9 (1), 5257, 2018 | 319 | 2018 |
| Systemic inflammation markers and cancer incidence in the UK Biobank TH Nøst, K Alcala, I Urbarova, KS Byrne, F Guida, TM Sandanger, ... European journal of epidemiology 36 (8), 841-848, 2021 | 232 | 2021 |
| Physical activity of UK adults with chronic disease: cross-sectional analysis of accelerometer-measured physical activity in 96 706 UK Biobank participants DT Barker J, Smith Byrne K, Doherty A, Foster C, Rahimi K, Ramakrishnan R ... International Journal of Epidemiology, 2019 | 166 | 2019 |
| Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction L Kachuri, RE Graff, K Smith-Byrne, TJ Meyers, SR Rashkin, E Ziv, ... Nature communications 11 (1), 6084, 2020 | 140 | 2020 |
| Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study R Ramakrishnan, A Doherty, K Smith-Byrne, K Rahimi, D Bennett, ... PLoS medicine 18 (1), e1003487, 2021 | 131 | 2021 |
| Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with∼ 430 000 women N Murphy, A Knuppel, N Papadimitriou, RM Martin, KK Tsilidis, ... Annals of Oncology 31 (5), 641-649, 2020 | 126 | 2020 |
| Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins F Guida, N Sun, LE Bantis, DC Muller, P Li, A Taguchi, D Dhillon, ... JAMA oncology 4 (10), e182078-e182078, 2018 | 113 | 2018 |
| A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort KL Terry, H Schock, RT Fortner, A Hüsing, RN Fichorova, HS Yamamoto, ... Clinical Cancer Research 22 (18), 4664-4675, 2016 | 108 | 2016 |
| Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis M Nazarzadeh, Z Bidel, D Canoy, E Copland, M Wamil, J Majert, ... The Lancet 398 (10313), 1803-1810, 2021 | 97 | 2021 |
| Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence S Moody, S Senkin, SMA Islam, J Wang, D Nasrollahzadeh, ... Nature genetics 53 (11), 1553-1563, 2021 | 93 | 2021 |
| Systolic blood pressure and risk of valvular heart disease: a Mendelian randomization study M Nazarzadeh, AC Pinho-Gomes, KS Byrne, D Canoy, F Raimondi, ... JAMA cardiology 4 (8), 788-795, 2019 | 84 | 2019 |
| Reallocation of time between device-measured movement behaviours and risk of incident cardiovascular disease R Walmsley, S Chan, K Smith-Byrne, R Ramakrishnan, M Woodward, ... British journal of sports medicine 56 (18), 1008-1017, 2022 | 76 | 2022 |
| Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: prospective analyses in UK Biobank A Knuppel, GK Fensom, EL Watts, MJ Gunter, N Murphy, K Papier, ... Cancer research 80 (18), 4014-4021, 2020 | 74 | 2020 |
| Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank EL Watts, GK Fensom, K Smith Byrne, A Perez‐Cornago, NE Allen, ... International journal of cancer 148 (9), 2274-2288, 2021 | 58 | 2021 |
| Association between musculoskeletal pain at multiple sites and objectively measured physical activity and work capacity: results from UK Biobank study F Pan, KS Byrne, R Ramakrishnan, M Ferreira, T Dwyer, G Jones Journal of science and medicine in sport 22 (4), 444-449, 2019 | 42 | 2019 |
| Self-reported and objectively measured physical activity in people with and without chronic heart failure: UK Biobank analysis J O'Donnell, K Smith-Byrne, C Velardo, N Conrad, G Salimi-Khorshidi, ... Open heart 7 (1), e001099, 2020 | 37 | 2020 |
| Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian … EL Watts, A Perez-Cornago, GK Fensom, K Smith-Byrne, U Noor, ... International journal of epidemiology 52 (1), 71-86, 2023 | 33 | 2023 |
| Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia EL Watts, A Perez‐Cornago, GK Fensom, K Smith‐Byrne, U Noor, ... International journal of cancer 151 (7), 1033-1046, 2022 | 32 | 2022 |
| Vasectomy and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) K Smith, null Byrne, JM Castaño, MD Chirlaque, H Lilja, A Agudo, ... Journal of Clinical Oncology 35 (12), 1297-1303, 2017 | 31 | 2017 |
| Prospective identification of elevated circulating CDCP1 in patients years before onset of lung cancer S Dagnino, B Bodinier, F Guida, K Smith-Byrne, D Petrovic, MD Whitaker, ... Cancer research 81 (13), 3738-3748, 2021 | 28 | 2021 |
Mattias JohanssonInternational Agency for Research on Cancer (IARC)在 iarc.fr 的电子邮件经过验证
